PhotoCure ASA (PhotoCure ASA) FCF Margin % : 1.94% (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is PhotoCure ASA FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PhotoCure ASA's Free Cash Flow for the three months ended in Mar. 2024 was $0.22 Mil. PhotoCure ASA's Revenue for the three months ended in Mar. 2024 was $11.12 Mil. Therefore, PhotoCure ASA's FCF Margin % for the quarter that ended in Mar. 2024 was 1.94%.

As of today, PhotoCure ASA's current FCF Yield % is 3.05%.

The historical rank and industry rank for PhotoCure ASA's FCF Margin % or its related term are showing as below:

PHCUF' s FCF Margin % Range Over the Past 10 Years
Min: -27.95 Med: -1.73 Max: 9.58
Current: 9.58

During the past 13 years, the highest FCF Margin % of PhotoCure ASA was 9.58%. The lowest was -27.95%. And the median was -1.73%.

PHCUF's FCF Margin % is ranked better than
75.49% of 1028 companies
in the Drug Manufacturers industry
Industry Median: 0.06 vs PHCUF: 9.58

PhotoCure ASA FCF Margin % Historical Data

The historical data trend for PhotoCure ASA's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA FCF Margin % Chart

PhotoCure ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

6.95

5.45

5.60

-1.43

7.19

PhotoCure ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-10.31	19.27	2.58	11.48	1.94

Competitive Comparison of PhotoCure ASA's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PhotoCure ASA's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PhotoCure ASA's FCF Margin % falls into.

PhotoCure ASA FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PhotoCure ASA's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	3.412	/	47.458
	=	7.19 %

PhotoCure ASA's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0.216	/	11.123
	=	1.94 %

PhotoCure ASA FCF Margin % Related Terms

Thank you for viewing the detailed overview of PhotoCure ASA's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PhotoCure ASA (PhotoCure ASA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OTCPK:PHCUF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

PHOO:Sweden PHO:Norway

Address

Hoffsveien 4, Oslo, NOR, 0275

Website

https://www.photocure.com

PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, Netherlands, Other European countries, and the United States.